Q&A with Sinovac CEO

<p>The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech for emergency use.</p><p>WHO recommends the vaccine for use in people 18 years and older, in a two-dose schedule with a spacing of two to four weeks, according to a statement.</p><p>The efficacy results showed that the Sinovac vaccine prevented symptomatic disease in 51 percent of those vaccinated, and prevented severe COVID-19 and hospitalization in 100 percent of the studied population, according to the WHO&#39;s Strategic Advisory Group of Experts on Immunization (SAGE).</p><p>What do you want to know about China&#39;s Sinovac COVID-19 vaccine? We&#39;ve invited Yin Weidong, chairman and CEO of Sinovac, to answer your questions.</p><p><br/></p>